D-fluoromethyltyrosine F-18 Uses, Dosage, Side Effects and more
D-fluoromethyltyrosine F-18 is under investigation in clinical trial NCT01089998 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations).
| Trade Name | D-fluoromethyltyrosine F-18 |
| Generic | D-fluoromethyltyrosine F-18 |
| Type | |
| Formula | C10H12FNO3 |
| Weight | Average: 212.211 Monoisotopic: 212.082655917 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
